General Information of Drug (ID: DMQZ62O)

Drug Name
mRNA-3705
Indication
Disease Entry ICD 11 Status REF
Methylmalonic acidemia 5C50.E0 Phase 2 [1]
Drug Type
mRNA
Cross-matching ID
TTD ID
DR07XM

References

1 ClinicalTrials.gov (NCT05295433) A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in the mRNA-3705-P101 Study. U.S.National Institutes of Health.